Relationships between genetic polymorphisms and transcriptional profiles for outcome prediction in anticancer agent treatment

Cited 2 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorHyojung Paik-
dc.contributor.authorE Lee-
dc.contributor.authorD Lee-
dc.date.accessioned2017-04-19T09:21:10Z-
dc.date.available2017-04-19T09:21:10Z-
dc.date.issued2010-
dc.identifier.issn1225-8687-
dc.identifier.uri10.5483/BMBRep.2010.43.12.836ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/9931-
dc.description.abstractIn the era of personal genomics, predicting the individual response to drug-treatment is a challenge of biomedical research. The aim of this study was to validate whether interaction information between genetic and transcriptional signatures are promising features to predict a drug response. Because drug resistance/susceptibilities result from the complex associations of genetic and transcriptional activities, we predicted the inter-relationships between genetic and transcriptional signatures. With this concept, captured genetic polymorphisms and transcriptional profiles were prepared in cancer samples. By splitting ninety-nine samples into a trial set (n = 30) and a test set (n = 69), the outperformance of relationship-focused model (0.84 of area under the curve in trial set, P = 2.90 × 10-4) was presented in the trial set and validated in the test set, respectively. The prediction results of modeling show that considering the relationships between genetic and transcriptional features is an effective approach to determine outcome predictions of drug-treatment.-
dc.publisherKorea Soc-Assoc-Inst-
dc.titleRelationships between genetic polymorphisms and transcriptional profiles for outcome prediction in anticancer agent treatment-
dc.title.alternativeRelationships between genetic polymorphisms and transcriptional profiles for outcome prediction in anticancer agent treatment-
dc.typeArticle-
dc.citation.titleBMB Reports-
dc.citation.number12-
dc.citation.endPage841-
dc.citation.startPage836-
dc.citation.volume43-
dc.contributor.affiliatedAuthorHyojung Paik-
dc.contributor.alternativeName백효정-
dc.contributor.alternativeName이은정-
dc.contributor.alternativeName이도헌-
dc.identifier.bibliographicCitationBMB Reports, vol. 43, no. 12, pp. 836-841-
dc.identifier.doi10.5483/BMBRep.2010.43.12.836-
dc.subject.keywordAnticancer agents-
dc.subject.keywordDrug response-
dc.subject.keywordIndividual variation-
dc.subject.keywordPrediction model-
dc.subject.keywordRelationship-
dc.subject.localAnticancer Agents-
dc.subject.localAnti-cancer agents-
dc.subject.localanti-cancer agent-
dc.subject.localAnti-cancer agent-
dc.subject.localAnticancer agent-
dc.subject.localAnticancer agents-
dc.subject.localAnticancer Agent-
dc.subject.localanticancer agent-
dc.subject.localDrug response-
dc.subject.localIndividual variation-
dc.subject.localprediction model-
dc.subject.localPrediction model-
dc.subject.localRelationships-
dc.subject.localRelationship-
dc.subject.localrelationship-
dc.description.journalClassY-
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.